Detalhe da pesquisa
1.
Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019.
J Infect Dis
; 229(1): 10-18, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988167
2.
Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
Vox Sang
; 119(3): 212-218, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38152857
3.
An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT.
Vox Sang
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516962
4.
International review of blood donation nucleic acid amplification testing.
Vox Sang
; 119(4): 315-325, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390819
5.
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance.
Vox Sang
; 118(10): 843-853, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694766
6.
Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali.
Emerg Infect Dis
; 28(12): 2463-2471, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343384
7.
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Blood
; 136(20): 2290-2295, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959052
8.
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in France.
Transfusion
; 62(3): 633-640, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089597
9.
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France.
Vox Sang
; 117(12): 1411-1414, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394899
10.
COVID-19 convalescent plasma: Evolving strategies for serological screening in France.
Vox Sang
; 117(4): 606-610, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897745
11.
Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant.
Vox Sang
; 117(7): 971-975, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577569
12.
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
Euro Surveill
; 26(27)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240697
13.
Chikungunya, a Risk Factor for Guillain-Barré Syndrome.
Clin Infect Dis
; 70(6): 1233-1235, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290540
14.
Risk for Hepatitis E Virus Transmission by Solvent/Detergent-Treated Plasma.
Emerg Infect Dis
; 26(12): 2881-2886, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219652
15.
Zika Virus Circulation in Mali.
Emerg Infect Dis
; 26(5): 945-952, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310065
16.
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
Vox Sang
; 115(6): 488-494, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240545
17.
Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017.
Euro Surveill
; 25(5)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32046820
18.
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016.
Am J Epidemiol
; 188(7): 1389-1396, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995296
19.
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.
N Engl J Med
; 374(1): 33-42, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735992
20.
Viral load and clinical manifestations of hepatitis E virus genotype 3 infections.
J Viral Hepat
; 26(9): 1139-1142, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099059